← All trials
NCT00368264
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2006
- Primary completion
- Jun 1, 2009
- Completion date
- Jun 1, 2009
- First posted
- —
- Last posted
- —
- Enrollment
- 1
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of ViennaLead sponsor
- University of ViennaStudy chair
- University of ViennaOverall official - principal investigator
- Humboldt UniversityOverall official - principal investigator
- Radboud UniversityCollaborator
- Leiden UniversityCollaborator
- University of GroningenCollaborator
- Medical University of GrazCollaborator
- Hospital HietzingCollaborator
- University of GroningenOverall official - principal investigator
- University of Erlangen-NurembergCollaborator
- Humboldt UniversityCollaborator
- University of DuesseldorfCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.